Healthcare -
Biotechnology - NASDAQ - US
$ 6.17
6.56 %
$ 192 M
Market Cap
-2.32
P/E
ACRV - TOTAL CURRENT LIABILITIES
Total Current Liabilities ACRV - Acrivon Therapeutics, Inc. Common Stock
13.3 M
LAST VALUE
113.66%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR